Dimebom is a new pharmaceutical treatment alternative for patients suffering from Alzheimer’s Disease. Dimebon is an older medication that has recently been discovered to be most helpful in treating patients with Alzheimer’s Disease . Dimebon ( the actual drug is known chemically as Dimebolin) is an older Russian antihistamine drug. It was popularly used in Russia as an antihistamine for hayfever , allergies and the like. In fact the drug was sold as an easy to obtain antihistamine – sold over the counter without a prescription.

Dimebon is currently in clinical trials in the United States by a company named Medivation The website for Medivation , the pharmaceutical company involved with the clinical development and testing of Dimebon in the United States can be found at link www.medivation.com . To learn more about Medivation’s clinical trials of Dimebon the link is

http://bit.ly/MedivationClinicalTrials

For more information on CONNECTION study locations, eligibility and enrollment, please visit www.connectionstudy.com or call toll-free 1-877-888-6386

At this point in time Dimebon is not available in any manner to Alzheimer Patients or their families , outside of the study material afforded by the Medivation company and the Medivation clinical trials themselves.

Dimebon Alzheimer’s Disease

http://www.dimebonalzheimers.com